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ABSTRACT
Subcellular protein compartmentalization is one of the strategies that nature has 
adapted for various functions, such as storage and protection of cargo molecules as well 
as regulation of chemical reactions. There is a growing interest among nanotechnologists 
to utilize protein capsids for encapsulating guest molecules in bioimaging, drug-delivery, 
nanoreactors, etc. To date, many viral and nonviral protein capsids have been 
investigated for those applications.
We used an engineered an Aquifex aeolicus lumazine synthase variant (AaLS-13) 
as a platform to encapsulate a guest enzyme by charge complementarity. The enzyme, 
esterase Est55 bearing a C-terminal deca-arginine (R10) tag, was placed in the lumen of 
the AaLS-13 during the self-assembly of the capsid when co-produced in E. coli. This 
encapsulated enzyme was characterized by colorimetric assay with the substrate, p- 
nitrophenyl acetate. Comparison of the specific esterase activity between the empty 
capsid and the enzyme-loaded capsid showed 64-fold higher specific activity in the 
enzyme-loaded capsid compared to the empty capsid. Mass spectrometry and proteomics 
analysis verified that the presence of Est55-R10 in a sample of purified AaLS-13 that had 
been co-produced with the esterase. Capsid loading was estimated by esterase activity 
measurements and SDS-PAGE analysis. Both methods gave a loading estimate of one 
esterase molecule per eleven capsids.
We plan to improve capsid loading using “supercharged” esterases. We also plan 
to investigate the porosity of the capsid because size limit for small molecule diffusion in 
and out of capsid is not well defined. Esterase substrates of various sizes will be applied 
to both esterase-loaded capsid and free esterase to determine the molecular weight cut-off 
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CHAPTER 1
INTRODUCTION
Icosahedral protein capsids are highly symmetric structures that enclose a central 
cavity, which isolates the interior environment from the bulk solution.1 These soccer ball­
like structures are often the product of self-assembly by multiple identical subunits. 
Viruses provide many examples of such protein cages, in which the viral capsid secures 
and carries its infectious genetic information. Protein capsids are not limited to viruses, 
and in nature these assemblies often encapsulate enzymes to function as nanoscale 
reaction vessels. Such reactions include carbon fixation, propanediol utilization, and 
ethanolamine utilization.2
The ethanolamine utilization bacterial microcompartment is one of the most 
extensively studied natural nanoreactors. A major role of this subcellular 
microcompartment is to produce energy via the action of encapsulated guest enzymes, 
which convert the substrate, ethanolamine to acetyl CoA and ethanol. The potentially 
toxic intermediate, acetaldehyde, is not released into the cytosol because its high local 
concentration in the capsid promotes efficient capture by enzyme active sites, and the 
tightly packed protein shell presents a barrier to diffusion of the intermediate into bulk 
solution. The microcompartment has gated pores as well that selectively allow its
substrate to penetrate the protein shell3 in response to cellular conditions. Thus the 
enzyme activity is enhanced and regulated.
Natural molecular containers can also be useful for nanotechnology. Their narrow 
size distribution and easy modification by genetic methods make protein capsids 
particularly attractive as platforms for nanotechnological applications. To date, viral and 
non-viral self-assembled protein cages have been employed as delivery vehicles,4-7 
bioimaging agents,8-11 inorganic nanoparticle synthesis vessels,12,13 and nanoreactors14-16.
Demands for employment of enzymes and whole cells as biocatalysts have been 
increased in industries such as foods, drinks, fine chemicals, etc. Biotechnologists want to 
develop efficient enzyme catalysts that can be regulated in a sophisticated manner. 
Although there have been several attempts to build nanoreactors with proteinaceous,10-12 
liposomal,17 and dendritic18 containers, none of them are necessarily designed to regulate 
enzyme activity in a systematic manner. Here, we aim to construct an artificial bio­
inspired nanoreactor in which an esterase enzyme acts as the guest and a bacterial protein 
capsid acts as the host.
1.1 Capsid Protein: Lumazine Synthase from Aquifex aeolicus (AaLS)
The capsid formed by lumazine synthase (AaLS) is a particularly promising 
scaffold for developing novel encapsulation systems. It is an enzyme that catalyzes the 
penultimate step of riboflavin synthesis (Figure 1.1). AaLS forms a hollow icosahedral 
capsid by self-assembly with 60 identical subunits. This capsid is highly thermostable 
with the melting temperature of 120 °C.19
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Figure 1.1. Riboflavin synthesis by the lumazine synthase/riboflavin synthase complex. 1, 
5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione; 2, 3,4-dihydroxy-2-butanone; 3, 
6,7-dimethyl-8-ribityllumazine; 4, riboflavin.
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The AaLS capsid has pores located at every five-fold symmetry axis. The pore 
has a roughly cylindrical shape with a relatively wide opening at the inner and the outer 
surfaces whereas halfway in between the pore is narrower. The pore is believed to serve 
as a tunnel for the substrates that have to penetrate the capsid and interact with the active 
site, which is located at the inner surface of the capsid.
Questions have been raised for many years as to how the substrate can arrive at 
the active site of the capsid and how the product can diffuse out. A homologous lumazine 
synthase from Bacillus subtilis (BsLS) also forms a capsid with 60 identical subunits, but 
BsLS is known to orchestrate riboflavin biosynthesis by encapsulating riboflavin 
synthase, a 66 kDa homotrimeric enzyme. An early modeling study revealed that the 
five-fold symmetric pore does provide sufficient space for passage of riboflavin out of
the capsid.20 However, it is not possible for a bulky riboflavin to diffuse out through the 
capsid pore without violating energetic criteria of the protein structure.21 This latter 
hypothesis suggests that alternative pores may exist in the capsid that are not apparent in 
the X-ray structure. As the porosity of the capsid is not well characterized, it is 
worthwhile to recount porosity of the capsid and to determine molecular weight cut-off 
for substrates.
Previously, AaLS has been engineered to encapsulate guest proteins by charge 
complementarity (Figure 1.2). On the interior surface of the wild type capsid, four of the 
most solvent accessible residues of a monomer have been mutated to glutamate. This 
mutated capsid is named AaLS-neg. Interestingly, the diameter of the mutated capsid is 
27 nm whereas that of wild type AaLS (AaLS-wt) is 16 nm. The AaLS-neg capsid 
assembles from 180 subunits rather than 60 subunits. Thus, AaLS-neg bears 720 
additional negative charges in the lumen of the capsid. AaLS-neg has been co-produced 
with a deca-arginine tagged GFP (GFP-R10) in E. coli. The capsids contain 3-4 GFP-R10 
molecules on average.22 AaLS-neg has been further engineered to enhance its loading 
capacity. Directed evolution of AaLS-neg to optimize its ability to encapsulate HIV- 
protease-R10 led to the selection of variant AaLS-13 containing five additional mutations 
at the subunit interfaces and two additional mutations at the interior surface. This time, an 
even bigger capsid has been formed with the diameter of 35 nm. AaLS-13 was found to 
encapsulate an average of seven HIV-protease-R10 dimers per capsid as measured by 
Western blot.23
4
5Figure 1.2. Encapsulation of guest molecules by AaLS capsid variants by charge 
complementarity. Rational design for AaLS-neg (R83E, T86E, T120E, and Q123E) and 
directed evolution for AaLS-13 (D28G, R52C, T112S, V115D, A118D, R127C and 
K131E) made it possible for the capsid to expand with enhanced guest molecule loading 
capacity. The colors used in the description of the mutations above corresponds to the 
highlighted residues in the structures of the AaLS-neg and AaLS-13 monomers shown in 
the figure.
According to the model for guest encapsulation shown in Figure 1.2, the guest 
enzyme should be in an active state. However it was not possible to detect the catalysis of 
the guest enzyme because the protease was not active at pH 8 where the capsid is stable, 
the capsid was not soluble below pH 6 where the protease is most active, and the 
substrates for the enzyme might have been too big to penetrate the capsid. Therefore, a 
new guest is needed to study catalysis of enzymes encapsulated by AaLS-13.
1.2 A New Guest Enzyme: Carboxylesterase (Est55)
The goal of this project is to study the influence of encapsulation on enzyme 
activity. The enzyme for the encapsulation system was carefully selected using the 
following five criteria. First, the enzyme should not contain disulfide bonds. Any 
disulfide bond will likely be reduced due to the reducing conditions in cytoplasm where 
the enzyme and the capsid are produced and assembled. Second, the enzyme should be 
independent from any cofactors. It is easier to assay an enzyme that can stand-alone, 
additionally problems may arise with the entry of cofactors into capsid pores. Third, the 
pH-rate profile of the enzyme should be known. The enzyme should show optimum 
activity near pH 8 to ensure compatibility with the capsid. Fourth, a convenient and 
sensitive assay for enzyme activity is required. Lastly, the encapsulated enzyme should 
have broad substrate specificity to permit experiments involving variations in substrate 
structure.
A carboxylesterase (Est55) from Geobacillus Stearothermophilus meets these 
criteria and was chosen to be the guest enzyme for these studies. Carboxylesterases have 
been shown catalyze the hydrolysis of a variety of substrates.25-28 Importantly, Est55 has 
a reported maximum activity at pH 8,26 which is the same pH at which previous studies 
with AaLS-13 have been carried out. A R10-tag has been fused to the C-terminus of Est55 
(Est55-R10) to promote its encapsulation in AaLS-13 upon co-production.29 The crystal 
structure of Est55 clearly shows that the C-terminus is remote from the active site on the 
opposite side of the enzyme (Figure 1.3), which is important because R 10-tag may 
interfere the catalysis of the enzyme if they are close to each other.
6
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Figure 1.3. Crystal structure of esterase (Est55). Est55 is a part of a/p hydrolase fold 
family. The active site contains catalytic triad with residues of Ser194, Glu310, and 
His409. The colors used in the list of the catalytic triad residues corresponds to the colors 
of the residues highlighted in the Est55 structure shown in the figure.
CHAPTER 2
RESULTS
Most enzyme activity measurements are done in bulk solution. However, 
sequestration of enzymes in nanocompartments can enhance the stability of enzymes and 
provide opportunities for activity regulation. As a proof of principle, we designed a bio­
inspired enzyme encapsulation system by charge complementarity. We aim to study the 
activity of encapsulated enzymes in comparison with free enzymes.
2.1 Stability of AaLS-13 
Capsid stability is an important feature for nanoreactor applications. AaLS-13 has 
been constructed by rational design and directed evolution.22,24 As mutations have been 
introduced at subunit interaction sites in the capsid, it decreased the thermal stability of 
the capsid. Further, production of the capsid in the absence of R10-tagged guest proteins 
leads to a mixture of properly assembled capsid and incompletely assembled capsid 
fragments. We wanted to know if the quaternary structure is prone to spontaneous 
disassembly. Three samples of AaLS-13 were produced in parallel E. coli cultures. The 
harvested cells were lysed and purified by an affinity column. Further purification of the 
three AaLS-13 protein samples was done by size exclusion chromatography on the same
day. Capsid-containing fractions for each of the three samples were pooled, concentrated 
to 1.5 mg/mL, and stored at 4 °C. Every 10 days, one of the samples was reinjected onto 
the size exclusion column. Over a total of 30 days, the chromatograms showed only 
minor differences, which indicate that the AaLS-13 capsid structure maintains a high 
quaternary structure resilience (Figure 2.1).
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2.2 Activity of Free Est55-R_i0 
p-Nitrophenyl acetate was used as a model substrate to measure esterase activity 
because it should be small enough to enter the capsid, the reaction could be monitored by 
a colorimetric assay (As405nm = 17800 M-1cm-1), and Est55 has been previously shown to 
efficiently hydrolyze the substrate.26
Volume (mL) Volume (mL)
Figure 2.1. AaLS-13 stability. Size exclusion chromatograms showed the quaternary 
structure of the capsid did not change over 30 days. Left: Chromatograms for the 
identical AaLS-13 samples injected immediately following Ni2+NTA affinity 
purification. Right: Chromatograms for the re-injection of each sample from left after the 
indicated incubation time.
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Michaelis-Menten kinetic analysis of Est55-R10 gave kcat, Km, and kcat/Km values 
of 910 s-1, 350 ^M, and 2.6 x 106 M 'V 1, respectively. These data confirm that Est55-R10 
efficiently hydrolyzes p-nitrophenyl acetate under our standard buffer conditions (Figure 
2.2). Kinetic assays at higher substrate concentrations were not feasible because of the 
solubility limit of the substrate in the assay buffer (0.5 % ethanol). Higher concentrations 
of a co-solvent that increased substrate solubility were detrimental to the activity of 
Est55-R10 (data not shown). Most importantly, these results indicated that Est55-R10 is a 







Figure 2.2. Michaelis-Menten kinetics of free Est55-R10. At [Est55-R10] = 1.2 nM, pH =
8.0, T = 30 °C, Vmax was determined to be 1.1 x 10-6 M/s from a fit of the data to the 
Michaelis-Menten equation.
2.3 Enzyme Encapsulation (Protein Production and Purification)
To generate an encapsulation complex of AaLS-13 and Est55-R10, the two 
proteins were co-produced in E. coli. In this co-production system, the genes encoding 
AaLS-13 and Est55-R10 were on separate plasmids, with both under the control of 
identical dual T7-salicylate promoter systems. Sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) analysis showed that over-production of both AaLS-13 
and Est55-R10 was induced by Isopropyl P-d-1-thiogalactopyranoside (IPTG) and 
salicylate, respectively (Figure 2.3). Unfortunately, upon co-production, the yield of 
Est55-R10 was substantially lower than the yield of AaLS-13. This relatively poor 
production of Est55-R10 could be explained by either Est55-R10-associated toxicity to E. 
coli or sub-optimal induction conditions. The toxicity hypothesis was tested by producing 
Est55-R10 alone. However, under these conditions, esterase production increased 
suggesting that the esterase is not very toxic to E. coli. An attempt was made to optimize 
co-production by systemically varying induction conditions such as the concentration of 
IPTG, concentration of salicylate, induction time, temperature, and the ratio of IPTG 
concentration to salicylate concentration. However, none of these changes significantly 
improved co-production. Therefore, we carried out the encapsulation studies using the 
standard co-production conditions mentioned in Materials and Methods.
2.4. Enzyme Activity of Loaded Capsid vs Empty Capsid 
After the affinity column purification, the AaLS-13 that was co-produced with 
Est55-R10 was further purified by size-exclusion chromatography. In comparison with 
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Figure 2.3. SDS-PAGE analysis of protein production and purification. (A) Capsid 
protein alone. a) Molecular weight standards. b) Flow-through from cell lysate after 
loading onto Ni-NTA column. c) Column wash with lysis buffer. d) Wash with lysis 
buffer containing 10 mM imidazole. e) Wash with lysis buffer containing 500 mM 
imidazole. f) Whole cells before induction. g) Whole cells after induction. (B) Co­
production of capsid protein with esterase. a) Whole cells before induction. b) Whole 
cells after induction. c) Flow-through from cell lysate after loading onto Ni-NTA. d) 
Column wash with lysis buffer. e) Wash with lysis buffer containing 10 mM imidazole. f) 
Wash with lysis buffer containing 500 mM imidazole. g) Molecular weight standards. (C) 
Esterase alone. a) Whole cells after induction. b) Same sample as in a), after dilution to 
OD600 = 0.57. c) Whole cells before induction with OD600 = 0.5. d) Molecular weight 
standards. Molecular weight of both capsid and esterase are 18 kDa and 56 kDa 
respectively.
similar early eluting peak, which can be attributed to the capsid. The fractions from the 
size-exclusion column were assayed for esterase activity (Figure 2.4). In the co- produced 
sample, a peak (fraction 12-14) in esterase activity was observed that corresponded with 
the elution of the capsid. A second esterase activity peak (fraction 22 and 23) was 
observed that might reflect either residual free esterase contamination in the sample or 
some low-level esterase activity of incompletely assembled AaLS-13 itself. In 
comparison, AaLS-13 produced without esterase showed lower esterase activity in the 
capsid-containing fractions, and the esterase activity was fairly constant over all protein- 
containing fractions.
Est55-Ri0 is an efficient catalyst of p-nitrophenyl acetate hydrolysis because it has 
a catalytic triad in its active site that is well suited to this function23. In contrast, AaLS-13 
would be expected to be an inefficient esterase because it lacks an organized active site
13
[Protein (mg/ml)] [Activity (M/s)] [Protein (mg/ml)] [Activity (M/s )]~ n,
Fraction Fraction
Figure 2.4. Enzyme activity comparison between loaded capsid and empty capsid. (A) 
Gel filtration chromatograph of AaLS-13 alone and its enzyme activity. (B) Gel filtration 
chromatograph of AaLS-13 co-produced with Est55-R10 and its enzyme activity.
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Table 2.1. Specific activity of capsid proteins from AaLS-13 and AaLS-13 co-produced 
with Est55-R10.
AaLS-13 AaLS-13 co-produced with 
Est55-R10
Specific Activity 
(prnol of product formed/ 
min/ mg of total protein)
4.0 x 10-3 
± 1.9 x 10-3
2.6 x 10-1 
± 1.3 x 10-1
suited to this function. Nonetheless, AaLS-13 may have significant p-nitrophenyl acetate 
activity because p-nitrophenyl acetate is a highly activated substrate, and the protein 
produced sample, a peak (fraction 12-14) in esterase activity was observed that 
corresponded with the elution of the capsid. A second esterase activity peak (fraction 22 
and 23) was observed that might reflect either residual free esterase contamination in the 
sample or some low-level esterase activity of incompletely assembled AaLS-13 itself. In 
comparison, AaLS-13 produced without esterase showed lower esterase activity in the 
capsid-containing fractions, and the esterase activity was fairly constant over all protein- 
containing fractions.
Est55-R10 is an efficient catalyst of p-nitrophenyl acetate hydrolysis because it has 
a catalytic triad in its active site that is well suited to this function23. In contrast, AaLS-13 
would be expected to be an inefficient esterase because it lacks an organized active site 
suited to this function. Nonetheless, AaLS-13 may have significant p-nitrophenyl acetate 
activity because p-nitrophenyl acetate is a highly activated substrate, and the protein 
contains many residues capable of acting as nucleophiles, acids, or bases such as 
histidines, lysines, glutamates, aspartates, the N-terminus, and the C-terminus.
We compared specific activities of the capsid containing fractions for AaLS-13 + 
Est55-R10 and AaLS-13 without esterase to verify that the elevated esterase activity was 
not due to AaLS-13 itself. From multiple enzyme activity measurements of different 
protein preparations, we found that the specific activity of the capsid-containing fractions 
(12-14) for AaLS-13 + Est55-R10 was 64-fold higher than that of AaLS-13 produced 
without esterase (Table 2.1).
2.5 Quantitation of Encapsulated Esterase 
The specific activity of free Est55-R10 with 100 ^M of the substrate was 220 prnol 
of product formed/ min/ mg of enzyme. If each AaLS-13 capsid is loaded with one Est55- 
R10 molecule, and if the activity of Est55-R10 is unaffected by encapsulation, we would 
expect the specific activity of this hypothetically loaded capsid to be 2.9 prnol of product 
formed/min/mg of total protein (both the esterase and the capsid, assuming 240 subunits 
for AaLS-13). Specific activity of the capsid fractions containing AaLS-13 and Est55-R10 
was 0.26 prnol of product formed/ min/ mg of total protein, which is about 11-fold lower 
than what would be expected for a loading efficiency of one esterase per capsid. This 
result suggests that either the catalytic activity of the enzyme inside the capsid has 
changed, or there is one Est55-R10 in every 11 capsids. Therefore, direct quantitation of 
encapsulated esterase will tell us which one of the two hypotheses is correct.
2.6 Quantitation of Encapsulated Esterase (2)
As an alternative to esterase activity, we turned to SDS-PAGE and mass 
spectrometry as a means for direct detection and quantitation of Est55-R10. The purified 
AaLS-13 + Est55-R10 complex was analyzed by SDS-PAGE at a high loading of protein
15
(27 p,g). Coomassie blue staining revealed a band whose mobility corresponds to free 
Est55-R10 (Figure 2.5).
The intensity of Est55-R10 band indicated that about 30 ng (0.53 pmol) of esterase 
was present in the sample. Assuming that the amount of AaLS-13 in the sample is close 
to the total amount of protein, about 6.3 pmols of AaLS-13 were loaded on the gel. This 
gives ratio of AaLS-13 to Est55-R10 as 11.6 : 1. This ratio is close to that expected from 
the observed activity if the encapsulated Est55-R10 is fully active.
There were multiple bands found on the gel from the sample in lane (A). The 
proteins in all four major bands were identified by liquid chromatography-mass 
spectrometry (LC-MS/MS). Of these four bands, the highest mobility band was found to 
be AaLS-13 and the lowest mobility band was assigned as Est55-R10, consistent with 
their similarities to the purified standards. The other two bands contained a 50S 
ribosomal protein and a 30S ribosomal protein. These ribosomal proteins are endogenous 
to and abundant in the E. coli cytoplasm and had been previously found to be
16
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Figure 2.5. Encapsulated esterase detection using SDS-page. (A) AaLS-13 co-produced 
with Est55-R10 (2.7 x 101 p,g). (B) Mixture of capsid (3.4 x 101 p,g) and esterase (1.2 x 
101 ng). (C) Mixture of capsid (3.4 x 101 p,g) and esterase (2.3 x 10-2 p,g). (D) Mixture of 
capsid (3.4 x 101 ^g) and esterase (4.5 x 10-2 p,g). (E) Mixture of capsid (3.4 x 101 ^g) 
and esterase (9.0 x 10-2 p,g). (F) Molecular weight standard.
adventitiously encapsulated by AaLS-13.24 Consistent with this expectation, these bands 






Our encapsulated enzyme activity study was carried out by carefully choosing 
both the capsid and the guest enzyme protein. Est55 has shown its efficient activity 
towards variable substrates at pH where the capsid is stable. A deca-arginine tag was 
fused to Est55 for its encapsulation in AaLS-13, and Est55-R10 actively hydrolyzed p- 
nitrophenyl acetate. Encapsulation of the enzyme was done by in vivo co-production in E. 
coli. The catalytic activity of the capsid co-produced with the enzyme was dramatically 
higher than that of the empty capsid. The loaded capsid showed 64-fold higher specific 
activity than that of the empty capsid. SDS-PAGE analysis of concentrated loaded capsid 
sample showed a protein band that corresponds to free Est55-R10. Comparison of the 
Est55-R10 gel band intensity to purified standards of free Est55-R10 gave a rough estimate 
of the capsid loading that corresponds to one esterase per 11 capsids. This estimate is in 
gratifying agreement with an independent determination of capsid loading based on 
catalytic activity.
There is uncertainty about the subunit stoichiometry of the AaLS-13 capsid. 
AaLS-13 was generated by rational design and directed evolution. As a consequence, five 
residues at subunit interfaces are mutated. Some of the mutations eliminated previously 
established salt bridges in the subunit interaction site of AaLS-wt. The diameter of AaLS-
13 is 34.7 ± 3.4 nm, which is slightly larger than that of AaLS-neg (28.6 ± 2.6 nm).24 We 
assume the expansion of the capsid may be due to either increasing the number of 
subunits in the capsid from 180 to 240 or an alternative packing of 180 subunits. To 
answer the question, we are currently using analytical ultra-centrifugation (AUC) to 
estimate molecular weight of the AaLS-13 capsid.
The activity of AaLS-13 co-produced with Est55-R10 can be compared with that 
of other controls (AaLS-13 co-produced with Est55 and AaLS-wt co-produced with 
Est55-R10). These controls lack charge complementarity either from the capsid or from 
the enzyme. Their loading capability should not be as efficient as our engineered 
nanoreactor system. Thus the esterase activity with p-nitrophenyl acetate of these controls 
would expected to be lower than that of AaLS-13 co-produced with Est55-R10.
The porosity of the capsid is the important enzyme activity-regulating factor of 
our nanoreactor. Assuming the five-fold symmetric pores in the AaLS-13 are the only 
entries for substrates, the encapsulated esterase should be inactive with substrates too 
large to fit through the pore (Table 3.1) (Figure 3.1). The determination of the molecular 
weight cut-off for capsid will inform efforts to develop more sophisticated nanoreactors.
19
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Table 3.1. Varying size of substrates.
Substrates Molecular Weight
0  f Y NOi
p-nitrophenyl acetate
181 Da























Figure 3.1. Estimated enzyme activity vs size of substrates.
CHAPTER 4
MATERIALS AND METHODS
Cell culture media, salts and chemical reagents were purchased from Sigma- 
Aldrich, Fisher scientific, Pierce biotechnology and Bio-rad. The protein analysis and 
identification were done by the Mass spectrometry and Proteomics Core Facility at 
University of Utah.
4.1 Protein Production and Purification
For overproduction of proteins, calcium competent BL21 DE3 E. coli cells were 
transformed with pMG-AaLS-13, pACYC-Est55-R10, and both at 42 °C for 45 s. Cell 
cultures were grown at 37 °C and 250 rpm in LB medium (500 ml) with ampicilin (100 
mg/L) until the O.D600 reached 0.6. For co-production with Est55-R10 or Est55-R10 alone 
chloramphenicol (100 mg/L) was supplemented. The cultures were induced with 0.1 mM 
final concentration of IPTG at 37 °C and 250 rpm for 4 h. After the induction, the cells 
were harvested by centrifugation at 2960 xg and 4 °C for 10 min.
The cell pellets were resuspended in 20 ml lysis buffer (50 mM sodium 
phosphate, 100 mM sodium chloride, pH 8.0) and lysed by incubation with lysozyme (5 
mg), RNase (0.6 mg), and ten units of DNase in ice followed by sonication (45 amp, total 
3 min of sonication in ice: 1 min pulse on followed by 1 min rest). Cell lysate
of either the capsid alone or the capsid co-produced with the esterase were cleared by 
centrifugation (12000 xg for 30 min at 4 °C) and loaded onto 10 ml Ni2+-NTA agarose 
resin (Qiagen) that had been equilibrated with a lysis buffer. Cell lysate of the esterase 
alone skipped Ni2+-NTA purification. After washing with both a lysis buffer (50 mL) and 
a lysis buffer containing 10 mM and 40 mM imidazole (50 mL), capsids were eluted with 
a lysis buffer containing 500 mM imidazole (15 mL) and the collection tube contains 2 
mL of 0.5 M EDTA. Protein purity was assessed by SDS-PAGE. Protein concentrations 
were determined using the Coomassie Plus Protein Assay Reagent (Thermo Scientific).
4.2 Gel Filtration Chromatography (Size Exclusion) 
and Ion-Exchange Column 
The AaLS-13 capsid and AaLS-13 co-produced with Est55-R10 were further 
purified by gel filtration chromatography using a HiPrep 16/60 Sephacryl S-400HR 
columns (GE healthcare). The protein was loaded to the column pre-equilibrated with gel 
filtration running buffer (50 mM sodium posphate, 300 mM NaCl, and 5 mM EDTA, pH 
8). The running temperature was 4 °C at a flow rate of 0.5 ml/min.
Crude Est55-R10 was loaded onto an cation-exchange MONO STM 5/50 column 
(GE healthcare). The column was pre-equilibrated with low-salt buffer A (50 mM sodium 
phosphate, 50 mM sodium chloride, and 5 mM EDTA, pH 8). The column bound Est55- 
R10 was eluted with a gradient from 0 to 100% ion-exchange buffer B (50 mM sodium 
phosphate, 2 M NaCl, and 5 mM EDTA, pH 8) over 40 mL at 4 °C.
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4.3 Enzyme Activity 
All experiments were run in duplicate, and all kinetic data analyzed with respect 
to the enzyme concentration except the capsid co-produced with Est55-R10 that were in 
respect to the total protein concentration (enzyme plus capsid). The activity and kinetics 
of purified AaLS-13 (11 pM), AaLS-13 co-produced with Est55-R10 (5.3 pM), and free 
Est55-R10 (1.2 nM) were analyzed with the substrate p-nitrophenyl acetate (Sigma- 
Aldrich) using a U-3310 spectrophotometer, HITACHI (absorbance 405 nm, 1500 s read 
time). For determinations of enzyme kinetics, several different concentrations of the 
substrate (25, 50, 100, 200, 400, 800 pM) were prepared in ethanol by serial dilutions: 5 
pl of each different substrate concentration were added to 1 ml of enzyme solution (50 
mM phosphate, 100 mM NaCl, 5 mM EDTA, pH 8) of Est55-R10 at 30 °C and read 
immediately. Concentration of each substrate was recalculated using Beer-Lambert law, 
A = elc by taking endpoint absorbance corresponding to 100% product and extinction 
coefficient of product (As = 17800 M '1cm'1).
Enzyme activity of AaLS-13 and AaLS-13 with Est55-R10 were measured for 
fractions (1 to 30) from the gel filtration column. Reaction conditions were identical to 
the free Est55-R10.
4.4 Encapsulated Esterase Detection 
Concentrated capsid sample (AaLS-13 co-produced with Est55-R10) was loaded 
on SDS-page gel (12% acrylamide, 150 V, for 60 min). Four of protein bands were 
analyzed and identified by LC-MS/MS in mass spectrometry and proteomics core facility 
at University of Utah.
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